APA (7th ed.) Citation

NH, T., S, B., N, B., E, D., A, M., P, R., . . . F, F. (2026). Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis. CPT: pharmacometrics & systems pharmacology, 15(6), e70225. https://doi.org/10.1002/psp4.70225

Chicago Style (17th ed.) Citation

NH, Truong, et al. "Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis." CPT: Pharmacometrics & Systems Pharmacology 15, no. 6 (2026): e70225. https://doi.org/10.1002/psp4.70225.

MLA (9th ed.) Citation

NH, Truong, et al. "Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis." CPT: Pharmacometrics & Systems Pharmacology, vol. 15, no. 6, 2026, p. e70225, https://doi.org/10.1002/psp4.70225.